ctrl K

Watchlist Price Alert

Prelude Therapeutics (PRLD)

NASDAQ: PRLD · Real-Time Price · USD

0.81

-0.05 (-5.81%)

At close: Jun 27, 2025, 3:59 PM

0.79

-2.93%

After-hours: Jun 27, 2025, 05:50 PM EDT

Prelude Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	7M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.17M	3.04M	2.24M	542K	382K	149K
Gross Profit	7M	-1.17M	-3.04M	-2.24M	-542K	-382K	-149K
Operating Income	-139.71M	-132.28M	-123.54M	-113.73M	-58.76M	-28.11M	-14.97M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-127.17M	-121.83M	-115.44M	-111.69M	-56.93M	-27.57M	-14.68M
Net Income	-127.17M	-121.83M	-107.34M	-110.78M	-56.93M	-27.57M	-14.68M
Selling & General & Admin	28.72M	28.88M	30.65M	26.96M	10.59M	3.83M	2.35M
Research & Development	118M	103.39M	92.89M	86.78M	48.18M	24.28M	12.62M
Other Expenses	n/a	n/a	8.1M	2.04M	1.83M	539K	295K
Operating Expenses	146.71M	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	146.71M	132.28M	123.54M	113.73M	58.76M	28.11M	14.97M
Income Tax Expense	n/a	n/a	-8.1M	-915K	335.7K	210.14K	295K
Shares Outstanding (Basic)	75.81M	60.36M	47.37M	47.6M	43.71M	32.4M	32.11M
Shares Outstanding (Diluted)	75.81M	60.36M	47.37M	47.6M	43.71M	32.4M	32.11M
EPS (Basic)	-1.68	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EPS (Diluted)	-1.68	-2.02	-2.27	-2.33	-1.3	-0.85	-0.46
EBITDA	-139.71M	-131.11M	-122.22M	-112.82M	-58.22M	-27.73M	-14.83M
EBIT	-139.71M	-132.28M	-123.54M	-113.73M	-58.76M	-28.11M	-14.97M
Depreciation & Amortization	n/a	1.17M	3.04M	2.24M	542K	382K	149K